Sensibilité au changement du score USP (Urinary Symptoms Profile) après traitement chirurgical de l’hypertrophie bénigne de la prostate (HBP)

Wakrim, B.; Kaboré, Fulgence; Sebbani, Majda; Sarf, I.; Amine, Mohamed; Lakhmichi, A.; Dahami, Z.; Moudouni, S.; Savoie, P.‐H.; Karsenty, G.

doi:10.1016/j.purol.2013.11.014

Cited by 2 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study noted a much higher rate of bladder dysfunction (76%) than previous investigations, with McCarthy et al finding 43% of patients to have bladder dysfunction at 5 years and Korse reporting 47% reducing to 41% on long-term follow-up [12, 15]. We hypothesise that this difference may be explained by the use of the objective USP score which is known to have a high sensitivity to a range of urological symptoms and patients would often report a symptom-free bladder, only to show dysfunction on the USP [27]. This conjecture is supported by the findings of Hellström et al who describe how although only 41% of CES patients complained of bladder dysfunction, urodynamic findings were abnormal in 76% [9].…”

Section: Discussionmentioning

confidence: 77%

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

et al. 2019

View full text Add to dashboard Cite

Background Data regarding long-term outcomes following surgery for cauda equina syndrome (CES) is scarce. In addition, these studies rely on patient descriptions of the presence or absence of symptoms, with no gradation of severity. This study aimed to assess long-term bladder, bowel, sexual and physical function using validated questionnaires in a CES cohort. Methods A pre-existing ethically approved database was used to identify patients who had undergone surgery for CES between August 2013 and November 2014. Patients were contacted over a 1-month period between August and September 2017 and completed validated questionnaires via telephone, assessing bladder (Urinary Symptom Profile), bowel (Neurogenic Bowel Dysfunction Score), sexual dysfunction (Arizona Sexual Experiences Scale) and physical function (Physical Component Summary of SF-12 Questionnaire), with scores compared between those presenting with incomplete CES (CES-I) and CES with retention (CES-R). Patients were also asked which of their symptoms currently they would most value treatment for and what healthcare services they had accessed post-operatively. Results Forty-six of 77 patients (response rate 72%, inclusion rate 60%) with a mean age of 45 years (21–83) and mean time since admission of 43 months (range 36–60) took part in the follow-up study. The prevalence of bladder dysfunction was 76%, bowel dysfunction 13%, sexual dysfunction 39% and physical dysfunction 48%. Patients presenting with CES-R had significantly worse long-term outcomes in bladder (stream domain), bowel and sexual function in compared to those with CES-I. Pain was chosen as the symptom patients would most value treatment for by 57%, but only 7% reported post-operative pain management referral. Conclusions With a mean follow-up time of 43 months, these findings confirm the high prevalence of long-term bladder, sexual and physical dysfunction in CES patients and that a diagnosis of CES-R confers poorer outcomes. This study provides useful, objective data to guide the expectations of patients and clinicians.

show abstract

Section: Discussionmentioning

confidence: 77%

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

et al. 2019

View full text Add to dashboard Cite

show abstract

Surgimesh M‐SLING^® transobturator and prepubic four‐arm urethral sling for post‐prostatectomy stress urinary incontinence: clinical prospective assessment at 24 months

Portz¹,

Haillot

Brouziyne³

et al. 2015

BJU International

View full text Add to dashboard Cite

ObjectiveTo assess tolerance and mid-term clinical outcomes of treatment, with a new four-arm mesh sling, of postprostatectomy incontinence (PPI) in men. Material and MethodsThis was a French multicentre prospective study that included 93 patients who underwent radical prostatectomy at least 1 year before Surgimesh M-SLING â implantation for the treatment of PPI. Data were collected preoperatively, and patients were followed at 3, 12 and 24 months postoperatively. Objective outcome measures included number of pads per day, 24-h pad-test, maximum urinary flow rate (Q max ) and urinary retention. We also analysed Urinary Symptom Profile (USP â ) score, degree of erectile dysfunction, patients' satisfaction level, postoperative pain and procedure complications. Length of catheterization and hospitalization periods were also recorded. Patients were considered cured if no protection was used and/or daily pad weight was <2 g. Patients whose condition was considered to have improved reduced their daily urinary losses by >50%. Those not included in any of the aforementioned groups were assessed as unchanged or to have deteriorated, and were considered as treatment failures. ResultsThe mean hospitalization period was 1.57 AE 0.70 days. All patients remained catheterized for 1.17 AE 0.48 days. Intention-to-treat analysis at 24 months showed that 34.4% of patients were cured, 27.1% had improved, and 19.4% were considered failures. Two patients experienced transient urinary retention. USP questionnaire scores showed a significant decrease in incontinence and prevalence of hyperactive bladder. There was a nonsignificant tendency for reduced severe erectile dysfunction (ED), and a shift towards moderate ED was observed. No severe complications occurred. ConclusionThe Surgimesh M-SLING transobturator and prepubic fourarm urethral sling represents an easy-to-deploy, safe and durable therapeutic alternative for mild to moderate PPI. Its implantation did not have a negative influence on sexual performance outcomes.

show abstract

Sensibilité au changement du score USP (Urinary Symptoms Profile) après traitement chirurgical de l’hypertrophie bénigne de la prostate (HBP)

Cited by 2 publications

References 13 publications

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

Surgimesh M‐SLING^® transobturator and prepubic four‐arm urethral sling for post‐prostatectomy stress urinary incontinence: clinical prospective assessment at 24 months

Contact Info

Product

Resources

About

Sensibilité au changement du score USP (Urinary Symptoms Profile) après traitement chirurgical de l’hypertrophie bénigne de la prostate (HBP)

Cited by 2 publications

References 13 publications

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

An assessment of patient-reported long-term outcomes following surgery for cauda equina syndrome

Surgimesh M‐SLING® transobturator and prepubic four‐arm urethral sling for post‐prostatectomy stress urinary incontinence: clinical prospective assessment at 24 months

Contact Info

Product

Resources

About

Surgimesh M‐SLING^® transobturator and prepubic four‐arm urethral sling for post‐prostatectomy stress urinary incontinence: clinical prospective assessment at 24 months